Monthly Prescribing Reference

Birth Control Patch With Lower Estrogen Dose Effective in Phase 3 Trial

The Company expects to submit the New Drug Application for Xulane Lo in the second half of 2025. A low dose combination hormonal patch was found to be effective for pregnancy prevention based on ...

Birth control ring and patch linked to higher clot, stroke risk, study says

Some hormonal birth control products, including the vaginal ring and skin patch, may increase the risk of a blood clot, heart attack or stroke, new research suggests. A peer-reviewed study published ...
Seeking Alpha

Viatris Announces Positive Results from Phase 3 Study of Investigational XULANE LO™ Low Dose Patch for Birth Control in Women of Childbearing Potential

PITTSBURGH, May 8, 2025 /PRNewswire/ -- Viatris Inc. (VTRS) (Nasdaq: VTRS), a global healthcare company, today announced positive results of its Phase 3 study (NCT05139121) evaluating the ...
Everyday Health

When Will You Get Your First Period After Stopping Birth Control?

More than 65 percent of women ages 15 to 49 in the United States use some form of birth control, and many of them are on hormonal birth control methods like the pill, patch, ring, implant, injections, ...